Mutans Streptococci, Lactobacilli and Caries Experience in Cystic Fibrosis Homozygotes, Heterozygotes and Healthy Controls

Caries Research

Volumn 35, Issue 6, 2001, Pages 407-411

  Aps, Johan K M ^a   Van Maele, G O G ^b   Claeys, G ^b   Martens, L C ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Caries experience; CRT bacteria; Cystic fibrosis

Indexed keywords

DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; BACTERIAL COUNT; CHI SQUARE DISTRIBUTION; CHILD; COMPARATIVE STUDY; CYSTIC FIBROSIS; DENTAL CARIES; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEALTH SURVEY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LACTOBACILLUS; MICROBIOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; OBSERVER VARIATION; REPRODUCIBILITY; SALIVA; STREPTOCOCCUS MUTANS; TEST STRIP;

ADOLESCENT; ADULT; AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHILD; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; DENTAL CARIES; DENTAL CARIES SUSCEPTIBILITY; DMF INDEX; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LACTOBACILLUS; MIDDLE AGED; OBSERVER VARIATION; REAGENT STRIPS; REPRODUCIBILITY OF RESULTS; SALIVA; STATISTICS, NONPARAMETRIC; STREPTOCOCCUS MUTANS;

EID: 0035522573     PISSN: 00086568     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047483     Document Type: Article

References (29)

1. Aitkin ML, Fail SB: Cystic fibrosis. Dis Mon 1993;39:1-52.
2. Bellon G, Gilly R: Antibiothérapie dans la mucoviscidose: Incertitudes et réalités. Rev Mal Respir 1990;7:203-208.
3. Fernald GW, Roberts MW, Boat TF: Cystic fibrosis: A current review. Pediatr Dent 1990;12: 72-78.
4. Gold OG, Jordan HV, Van Houte J: A selective medium for Streptococcus mutans. Arch Oral Biol 1973;18:1357-1364.
5. Human DB: Genetic and immunologic aspects of cystic fibrosis. Ann Allergy Asthma Immunol 1997;79:379-387.
6. Hodson ME: Cystic fibrosis: The disease. Monaldi Arch Chest Dis 1993;48:647-652.
7. Hughes JG, Griffith JF: Cystic fibrosis; in Hughes JG, Griffith JF (eds): Synopsis of Pediatrics, ed 6. St Louis, Mosby, 1984, pp 670-674.
8. Jiménez-Reyes M, Sanchez-Aguirre FJ: Sodium and chlorine concentrations in mixed saliva of healthy and cystic fibrosis children. Appl Radiat Isot 1996;47:273-277.
9. Kankaala T, Virtanen J, Larmas M: Timing of first fillings in the primary dentition and permanent first molars of asthmatic children. Acta Odontol Scand 1998;56:20-24.
10. Kargul B, Tanboga I, Ergeneli S, Karakoc F, Dagli E: Inhaler medicament effects on saliva and plaque pH in asthmatic children. J Clin Pediatr Dent 1998;22:137-140.
11. Kinirons MJ: Increased salivary buffering in association with a low caries experience in children suffering from cystic fibrosis. J Dent Res 1983;62:815-817.
12. Kinirons MJ: Dental health of children with cystic fibrosis: An interim report. J Paediatr Dent 1985;1:3-7.
13. Kinirons MJ: Dental health of patients suffering from cystic fibrosis in Northern Ireland. Community Dent Health 1989;6:113-120.
14. Kneist S, Heinrich-Weltzien R: Mikrobiologische Chair-side Tests: Entsorgung in der Zahnarztpraxis. Phillip J 1997;14:357-360.
15. Kneist S, Heinrich-Weltzien R, Laurisch L: Evaluation of a new caries risk test. Indep Dent 1999a;76-85.
16. Kneist S, Heinrich-Weltzien R, Stösser L: Speicheltests - mehr als eine Motivation? Quintessence Int 1998;49:139-148.
17. Kneist S, Laurisch L, Heinrich-Weltzien R: Der neue CRT: Mikrobiologischer Hintergrund zum Nachweis von S. mutans. Oralprophylaxe 1999b;22:180-185.
18. Larmas M: A new dip-slide technique for counting of salivary Lactobacilli. Proc Finn Dent Soc 1975;71:31-35.
19. Martens LC, Aps JKM, Van Maele GOG: Is oral health at risk in people with cystic fibrosis? Eur J Paediatr Dent 2001;2:22-27.
20. Martens LC, Robberecht E: Increased caries experience in 3 cystic fibrosis patients (abstract 110). Proc 15th IAPD Congr, Göteborg, 1995, p 94.
21. Pine CM, Pitts NB, Nugent ZJ: Guidance on the statistical aspects of training and calibration of examiners for surveys of child dental health: A BASCD coordinated dental epidemiology programme quality standard. Community Dent Health 1997;14(suppl 1):18-29.
22. Pitts NB, Evans DJ, Pine CM: British Association for the Study of Community Dentistry (BASCD) diagnostic criteria for caries prevalence surveys 1996/97. Community Dent Health 1997;14(suppl 1):6-9.
23. Rogosa M, Mitchell JA, Wiseman RF: A selective medium for isolation and enumeration of oral Lactobacilli. J Dent Res 1951;30:1711-1719.
24. Sheppard DN, Ostegaard LS: Understanding how cystic fibrosis mutations cause a loss of CL-channel function. Mol Med Today 1996;2: 290-297.
25. Twetman S, Fritzon B, Jensen B, Hallberg U, Stahl B: Pre- and post treatment levels of salivary mutans streptococci and lactobacilli in pre-school children. Int J Paediatr Dent 1999;9: 93-98.
26. Twetman S, Stahl B, Nederfors T: Use of strip-mutans test in the assessment of caries risk in a group of pre-school children. Int J Paediatr Dent 1994;4:245-250.
27. Tsui LC: Probing the basic defect in cystic fibrosis. Curr Opin Genet Dev 1991;1:4-10.
28. Wauters JG, Hendrickx J, Coucke P, Vits L, Stuer K, van Schil L, van der Auwera BJ, Van Elsen A, Dumon J, Willems PJ: Frequency of the phenylalanine deletion (delta F508) in the CF gene of Belgian cystic fibrosis patients. Clin Genet 1991;39):89-92.
29. WHO: Oral Health Surveys: Basic Methods, ed 4. Geneva, World Health Organization, 1997; http://www.whocollab.od.mah.se (accessed May 2001).